Qing He

Qing He


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YDYini Dang
Yini Dang
QHQing He
Qing He
SYSiyu Yang
Siyu Yang
HSHuaiqing Sun
Huaiqing Sun
YLYin Liu
Yin Liu
TWTing Wu
Ting Wu
Objectives: Despite significant advances in neuroscience, the mechanisms of AD are not fully understood. Single-cell RNA sequencing (scRNA-seq) techniques provide potential solutions to analyze cellular composition of complex brain tissue and explore cellular and molecular biological mechanisms of AD. Methods: We investigated cellular heterogeneity in AD via utilization of bioinformatic analysis of scRNA-seq in AD patients and healthy controls from the Gene Expression Omnibus (GEO) database. The “GOplot” package was applied to explore possible biological processes in oligodendrocytes, astrocytes, and oligodendrocyte progenitor cells (OPCs). Expression patterns and biological functions of differentially expressed genes (DEGs) from scRNA-seq data were validated in RNA sequencing data. DEGs in astrocytes interacted with ferroptosis-related genes in FerrDb. CCK-8 and EdU assays were performed to measure cell proliferation ability. ROS, Fe2+ level, mitochondrial membrane potentials, iron concentrations, and total iron binding capacity (TIBC) in serum were evaluated. Y-maze and elevated maze were used to measure anxiety-like behavior. Autonomous and exploration behaviors or learning and memory ability in mice were analyzed using open field test and novel object recognition test. Results: Multiple clusters were identified, including oligodendrocytes, astrocytes, OPCs, neurons, microglia, doublets, and endothelial cells. Astrocytes were significantly decreased in AD, while oligodendrocytes and OPCs increased. Cell-to-cell ligand–receptor interaction analysis revealed that astrocytes, neurons, and OPCs mainly established contacts with other cells via the NRG3–ERBB4 ligand–receptor pair. GO and KEGG analyses found that astrocytes were enriched in the ferroptosis pathway. FTH1 and SAT1 in astrocytes were identified as hub mRNAs associated with ferroptosis. Serum iron concentration of 5xFAD mice was higher than that of WT, and emotional and cognitive function were significantly impaired as compared to WT. Serum iron concentration was negatively correlated with number of astrocytes and percentage of time spent entering the novelty arm in the Y-maze test, while it was positively correlated with percentage of time spent in the central area. Meanwhile, number of astrocytes was negatively correlated with percentage of time spent in the central area, while it was positively correlated with percentage of time spent entering the novelty arm. Conclusions: Through scRNA-seq analysis, we found that ferroptosis was activated in astrocytes and may contribute to the pathophysiological process in the entorhinal cortex. FTH1 and SAT1 were identified to impact astrocyte ferroptosis. Emotional and cognitive impairment in AD was associated with astrocyte ferroptosis. Our findings provide clues to reveal the pathophysiological processes following AD at the cellular level and highlight potential drug targets for the treatment of AD.

3 November 2021 in Medical Science Monitor
Verified
Journal Article
Open access
DZDong Zhang
Dong Zhang
MHMingli He
Mingli He
QHQing He
Qing He
ZLZeheng Li
Zeheng Li
Blood Pressure Rhythm and Blood Pressure Variability as Risk Factors for White Matter Lesions: A Cross-Sectional Study - Article abstract #933880

2 February 2022 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
YZYu Zheng
Yu Zheng
YLYin Liu
Yin Liu
JWJiawen Wu
Jiawen Wu
YXYi Xie
Yi Xie
SYSiyu Yang
Siyu Yang
TWTing Wu
Ting Wu
Background: Cognitive decline is the most dominant and patient-oriented symptom during the development of Alzheimer’s disease (AD) and mild cognitive impairment (MCI). This study was designed to test the feasibility of hybrid convolutional neural networks and long-short-term memory (CNN-LSTM) modeling driven early decision-tailoring with the predicted long-term cognitive conversion in AD and MCI.Methods: Characteristics of patients with AD or MCI covering demographic features, clinical features, and time-dependent neuropsychological-related features were fused into the hybrid CNN-LSTM modeling to predict cognitive conversion based on a 4-point change in the AD assessment scale-cognition score. Treatment reassignment rates were estimated based on the actual and predicted cognitive conversion at 3 and 6 months according to the prespecified principle; that is if the ADAS-cog score of the patient declines less than 4 points or increases at either follow-up time point, the medical treatment recommended upon their diagnosis would be considered insufficient. Therefore, it is recommended to upgrade the medical treatment upon diagnosis. Actual and predicted treatment reassignment rates were compared in the general population and subpopulations categorized by age, gender, symptom severity, and the intervention subtypes.Results: A total of 224 patients were included in the analysis. The hybrid CNN-LSTM model achieved the mean AUC of 0.735 (95% CI: 0.701–0.769) at 3 months and 0.853 (95% CI: 0.814–0.892) at 6 months in predicting cognitive conversion status. The AUC at 6 months was significantly impacted when data collected at 3 months were withdrawn. The predicted cognitive conversion suggested a revision of medical treatment in 46.43% (104/224) of patients at 3 months and 54.02% (121/224) at 6 months as compared with 62.05% (139/224) at 3 months (p = 0.001) and 62.50% (140/224) at 6 months (p = 0.069) according to their actual cognitive conversion. No significant differences were detected between treatment reassignment rates estimated based on actual and predicted cognitive conversion in all directions at 6 months.Conclusion: Using the synergistic advances of deep learning modeling and featured longitudinal information, our hypothesis was preliminarily verified with the comparable predictive performance in cognitive conversion. Results provided the possibility of reassigned recommended treatment for those who may suffer from cognitive decline in the future. Considering the limited diversity of treatment strategies applied in this study, the real-world medical situation should be further simulated.

14 April 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
YDYuerong Dong
Yuerong Dong
DZDong Zhang
Dong Zhang
YZYan Zhang
Yan Zhang
QHQing He
Qing He
Objective: This study aims to evaluate the preliminary efficacy and safety of drug-coated balloon (DCB) angioplasty for treating symptomatic vertebral artery origin stenosis (VAOS) in a real-world setting and to investigate potential factors necessitating intraoperative bailout stenting (BS). Methods: This single-center retrospective study enrolled 121 consecutive symptomatic VAOS patients treated with DCB angioplasty at Xuzhou First People’s Hospital between January 2022 and December 2024. Patients were classified into the DCB group or the BS group based on the requirement for intraoperative bailout stenting. Stenosis rates were compared within the DCB group at baseline, immediately post-procedure, and at ≥3- and ≥12-month follow-up, as well as between the DCB and BS groups at corresponding time points. The least absolute shrinkage and selection operator (LASSO) regression and multivariable logistic regression were used for variable selection, and a nomogram was constructed and evaluated using the concordance index ( C -index) and the Hosmer–Lemeshow goodness-of-fit test. Results: Technical success was achieved in 94 patients (77.6%), while bailout stenting was required in 27 patients (22.3%). The median stenosis of the DCB group decreased from 83% at baseline to 36% immediately post-procedure ( p < 0.001) and remained stable at ≥3 months (43%) and ≥12 months (45%). At ≥3 months, stenosis was lower in the DCB group than in the BS group (40.5% vs. 47%, p < 0.05), whereas no significant difference was observed at ≥12 months (48% vs. 69%, p = 0.17). Multivariable analysis identified elevated diastolic blood pressure [odds ratio (OR) = 1.051, 95% CI: 1.011–1.093] and concomitant internal carotid artery stenosis (moderate stenosis: OR = 8.377, 95% CI: 1.977–35.493; severe stenosis or occlusion: OR = 6.346, 95% CI: 1.493–26.975) as independent predictors of bailout stenting. The nomogram demonstrated good discrimination ( C -index = 0.807, 95% CI: 0.709–0.906) and adequate calibration ( p = 0.9158). Conclusion: DCB angioplasty was associated with favorable angiographic durability in symptomatic VAOS, with similar long-term patency between balloon-only and bailout stent strategies. Higher diastolic blood pressure, and concomitant carotid stenosis were associated with bailout stenting.

22 April 2026 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
RZRuirui Zhang
Ruirui Zhang
HSHuaiqing Sun
Huaiqing Sun
YDYaxuan Di
Yaxuan Di
HCHui Cao
Hui Cao
CZChengliang Zhang
Chengliang Zhang
TWTing Wu
Ting Wu
Objective: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive and motor deficits. With its global prevalence increasing rapidly and no effective treatment available, early identification of high-risk individuals is critical. This study investigated the relationship between motor parameters extracted from virtual reality (VR) tasks, combined with sleep-related measures, and cognitive impairment in patients with mild cognitive impairment (MCI). Our goal was to determine whether integrating VR-derived digital markers with sleep quality metrics could provide an objective and clinically applicable tool for early detection. Methods: 66 participants were recruited, including 28 healthy controls (HC) and 38 patients with MCI. Cognitive status was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE). All participants performed two scenario-based VR tasks, during which task completion time, accuracy, and overall performance scores were recorded. Group differences were evaluated using independent-samples t-tests, and these behavioral features and sleep quality metrics were further incorporated into ROC analyze to assess predictive performance for distinguishing MCI from HC. Results: Compared with HC, patients with MCI reported significantly poorer sleep quality based on the Pittsburgh Sleep Quality Index (PSQI) and subdomains such as sleep latency and habitual sleep efficiency. In the VR tasks, MCI patients required more time and achieved lower accuracy than HC, consistent with MoCA and MMSE scores. Correlation analysis confirmed strong associations between VR performance metrics and cognitive test scores. Importantly, integrating VR-derived digital markers with sleep parameters yielded superior predictive accuracy for MCI (AUC = 0.863; sensitivity = 86.84%; specificity = 71.43%; p < 0.001) compared with single-modality models. Conclusion: VR-based cognitive and sensorimotor tasks, when combined with sleep quality assessments, offer a robust and noninvasive approach for the early identification of prodromal AD. This multimodal strategy holds promise for enhancing clinical decision-making and enabling timely interventions.